United States Pre-Market Tobacco Application Pharmacokinetics

NACompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

October 19, 2018

Primary Completion Date

November 21, 2018

Study Completion Date

November 28, 2018

Conditions
Nicotine DependenceNicotine Dependence, CigarettesTobacco UseTobacco Smoking
Interventions
OTHER

Virginia Tobacco flavored JUUL 5% ENDS

Treatment with Virginia Tobacco flavored JUUL 5% ENDS (10 puffs).

OTHER

Cool Mint flavored JUUL 5% ENDS

Treatment with Cool Mint flavored JUUL 5% ENDS (10 puffs).

OTHER

Mango flavored JUUL 5% ENDS

Treatment with Mango flavored JUUL 5% ENDS (10 puffs).

OTHER

Creme Brulee flavored JUUL 5% ENDS

Treatment with Creme Brulee flavored JUUL 5% ENDS (10 puffs).

OTHER

VUSE Solo e-cigarette

Treatment with VUSE Solo Original with 4.8% nicotine e-cigarette (10 puffs).

OTHER

Nicorette White Ice Mint 4mg nicotine polacrilex gum

Treatment with Nicorette White Ice Mint 4mg Nicotine polacrilex gum (30 minutes Chew and Park method)

OTHER

Usual Brand combustible cigarette

Treatment with usual brand cigarette (10 puffs).

Trial Locations (1)

66212

Vince & Associates Clinical Research, Overland Park

All Listed Sponsors
lead

Juul Labs, Inc.

INDUSTRY

NCT03719391 - United States Pre-Market Tobacco Application Pharmacokinetics | Biotech Hunter | Biotech Hunter